Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors
Clinical trial NCT05247905 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05247905
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-16
- Primary completion
- 2028-03-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.